DXR CEO Michael Feldschuh Buys 30,000 Shares
CEO Michael Feldschuh has increased his stake in DXR with a 30,000-share purchase.
Key Points
- On June 23, 2026, DXR's CEO Michael Feldschuh bought 30,000 shares, signaling strong insider confidence.
- Shares of DXR were trading at $10.32 on Friday, with multiple institutional investors opening new positions.
- Analysts from Ascendiant Capital and Maxim Group maintain 'buy' ratings with price targets ranging up to $25.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 23, 2026, DXR's Chief Executive Officer, Michael Feldschuh, purchased 30,000 shares of the company. This insider transaction did not occur under a pre-planned trading scheme, indicating a direct decision by Feldschuh to increase his stake in the company.
Other Institutional Activity in DXR
Several institutional investors have recently opened new positions in DXR. Thompson Siegel & Walmsley LLC initiated a stake with 232,120 shares valued at approximately $2.25 million. Vanguard Capital Management LLC also opened a new position, acquiring 48,280 shares worth about $469,282. Similarly, Aristides Capital LLC entered with 41,692 shares valued at $403,162. Meanwhile, Renaissance Technologies LLC slightly reduced its holdings by 210 shares, ending with 28,011 shares valued at $270,866.
DXR Stock Snapshot
Shares of DXR traded at $10.32 on Friday. The stock has seen various institutional investments, indicating interest in its potential. However, specific financial metrics such as market cap or P/E ratio were not available for a detailed snapshot.
$DXR stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at DXR
Alongside Michael Feldschuh's purchase, other insiders have been active in buying shares. Caleb Desrosiers, Robert Michel (CFO), Joy Goudie, Henry Cremisi, Jonathan Feldschuh (Chief Scientific Officer), and Edward Feuer all bought shares on June 23, 2026. Notably, Jonathan Feldschuh acquired 25,000 shares, while Robert Michel purchased 12,000 shares, reflecting a broad insider confidence in the company's prospects.
Analysts Set New Price Targets
Analysts remain optimistic about DXR. On March 17, 2025, Ascendiant Capital maintained its 'buy' rating with a price target of $25. Maxim Group reiterated its 'buy' rating with a $22 target on March 27, 2024. These ratings suggest continued confidence from analysts in DXR's future performance.
Bottom Line
DXR's CEO and other insiders have shown confidence by purchasing shares, while multiple institutional investors have opened new positions. Analysts are maintaining positive ratings, with price targets that suggest potential upside. However, as with all 13F filings and insider transactions, these actions reflect past decisions and may not indicate current positions.
Get DXR alerts
New 13F filings, insider trades, and analyst moves on $DXR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.